Alendronate Sodium Patent Expiration
Alendronate Sodium was first introduced by Organon Llc A Sub Of Organon And Co
Alendronate Sodium Patents
Given below is the list of patents protecting Alendronate Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Binosto | US7488496 | Effervescent compositions comprising bisphosphonates and methods related thereto |
Aug 11, 2023
(Expired) | Radius |
| Binosto | US7964212 | Effervescent compositions comprising phosphonates and methods related thereto |
Mar 06, 2023
(Expired) | Radius |
| Binosto | US9592195 | Stable effervescent bisphosphonate formulations with rapid solubilization characteristics | Dec 05, 2031 | Radius |
| Fosamax | US5358941 | Dry mix formulation for bisphosphonic acids with lactose |
Dec 02, 2012
(Expired) | Organon |
| Fosamax |
US5358941 (Pediatric) | Dry mix formulation for bisphosphonic acids with lactose |
Jun 02, 2013
(Expired) | Organon |
| Fosamax | US5462932 | Oral liquid alendronate formulations |
May 17, 2014
(Expired) | Merck |
| Fosamax |
US5462932 (Pediatric) | Oral liquid alendronate formulations |
Nov 17, 2014
(Expired) | Merck |
| Fosamax | US5681590 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon |
| Fosamax |
US5681590 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon |
| Fosamax | US5994329 | Method for inhibiting bone resorption |
Jul 17, 2018
(Expired) | Merck |
| Fosamax |
US5994329 (Pediatric) | Method for inhibiting bone resorption |
Jan 17, 2019
(Expired) | Merck |
| Fosamax | US6015801 | Method for inhibiting bone resorption |
Jul 17, 2018
(Expired) | Merck |
| Fosamax |
US6015801 (Pediatric) | Method for inhibiting bone resorption |
Jan 17, 2019
(Expired) | Merck |
| Fosamax | US6090410 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon |
| Fosamax |
US6090410 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon |
| Fosamax | US6194004 | Dry mix formulation for bisphosphonic acids |
Dec 02, 2012
(Expired) | Organon |
| Fosamax |
US6194004 (Pediatric) | Dry mix formulation for bisphosphonic acids |
Jun 02, 2013
(Expired) | Organon |
| Fosamax | US6225294 | Method for inhibiting bone resorption |
Jul 17, 2018
(Expired) | Merck |
| Fosamax |
US6225294 (Pediatric) | Method for inhibiting bone resorption |
Jan 17, 2019
(Expired) | Merck |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Alendronate Sodium Generics
Several generic applications have been filed for Alendronate Sodium. The first generic version for Alendronate Sodium was by Impax Laboratories Inc and was approved on Feb 6, 2008. And the latest generic version is by Ipca Laboratories Ltd and was approved on Jun 4, 2024.
Given below is the list of companies who have filed for Alendronate Sodium generic.
1. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 35MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2008 |
| EQ 70MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2008 |
2. CIPLA
Cipla Ltd has filed for 5 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Cipla.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 35MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 70MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
3. RISING
Rising Pharma Holding Inc has filed for 4 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 35MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2008 |
| EQ 70MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2008 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2008 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2008 |
4. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 5 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 35MG BASE | tablet | Discontinued | ORAL | N/A | Apr 22, 2009 |
| EQ 70MG BASE | tablet | Discontinued | ORAL | N/A | Apr 22, 2009 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Apr 22, 2009 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Apr 22, 2009 |
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Apr 22, 2009 |
5. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
6. WATSON LABS
Watson Laboratories Inc has filed for 3 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 35MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 70MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
7. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Teva Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 70MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2008 |
| EQ 35MG BASE | tablet | Discontinued | ORAL | N/A | Aug 4, 2008 |
8. HANGZHOU BINJIANG
Hangzhou Minsheng Binjiang Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Hangzhou Binjiang.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 24, 2009 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 24, 2009 |
| EQ 35MG BASE | tablet | Prescription | ORAL | AB | Sep 24, 2009 |
| EQ 70MG BASE | tablet | Prescription | ORAL | AB | Sep 24, 2009 |
9. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 70MG BASE/75ML
(reference standard) | solution | Prescription | ORAL | AA | Feb 25, 2013 |
10. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 35MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 70MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
11. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 35MG BASE | tablet | Prescription | ORAL | AB | Sep 10, 2008 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Sep 10, 2008 |
| EQ 70MG BASE | tablet | Prescription | ORAL | AB | Sep 10, 2008 |
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Sep 10, 2008 |
12. IMPAX LABS INC
Impax Laboratories Inc has filed for 5 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2008 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2008 |
| EQ 35MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2008 |
| EQ 40MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2008 |
| EQ 70MG BASE | tablet | Discontinued | ORAL | N/A | Feb 6, 2008 |
13. JUBILANT CADISTA
Jubilant Cadista Pharmaceuticals Inc has filed for 4 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 35MG BASE | tablet | Discontinued | ORAL | N/A | Feb 18, 2010 |
| EQ 70MG BASE | tablet | Discontinued | ORAL | N/A | Feb 18, 2010 |
| EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | Feb 18, 2010 |
| EQ 10MG BASE | tablet | Discontinued | ORAL | N/A | Feb 18, 2010 |
14. IPCA LABS LTD
Ipca Laboratories Ltd has filed for 4 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Ipca Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Jun 4, 2024 |
| EQ 40MG BASE | tablet | Prescription | ORAL | AB | Jun 4, 2024 |
| EQ 35MG BASE | tablet | Prescription | ORAL | AB | Jun 4, 2024 |
| EQ 70MG BASE | tablet | Prescription | ORAL | AB | Jun 4, 2024 |
15. APOTEX
Apotex Inc has filed for 4 different strengths of generic version for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 5MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 10MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 35MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
| EQ 70MG BASE | tablet | Prescription | ORAL | AB | Aug 4, 2008 |
16. NOVITIUM PHARMA
Novitium Pharma Llc has filed for 1 generic for Alendronate Sodium. Given below are the details of the strengths of this generic introduced by Novitium Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 70MG BASE/75ML | solution | Prescription | ORAL | AA | May 11, 2023 |